North Carolina will receive more than $350,000 from the drug manufacturer Amgen as part of a settlement over allegations that the company offered kickbacks to pharmacies, Attorney General Roy Cooper's office announced Monday.

The $24.9 million settlement resolves allegations that Amgen provided certain pharmacies with rebates on the kidney drug Aranesp in exchange for a promise that the pharmacies would promote the drug in nursing home programs.

The company hoped to entice medical professionals in the nursing homes to dispense Aranesp instead of competing drugs, according to the attorney general's office.

North Carolina will get nearly $1.2 million from a $612 million settlement with pharmaceutical giant Amgen over fraudulent Medicaid claims, kickbacks and other misrepresentations.

As part of the settlement with federal prosecutors, the California drug company pleaded guilty Tuesday to a misdemeanor count of promoting an anemia drug for higher doses than it was approved.

The federal settlement ended an eight-year investigation based on 10 whistleblower cases filed in New York, Massachusetts and Washington state.

North Carolina's portion of the settlement was reached by the N.C. Attorney General's Medicaid Investigations Division and the N.C. Division of Medical Assistance.